GB PHARMA ApS: Financial statements 2023
CVR: 36054220
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
GB PHARMA ApS (CVR 36054220) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 22,285 and a net result of DKK -30,932 compared with DKK 65,154 the year before. That is a decrease of 47.8% compared with the year before. The profit margin was -138.8%. Equity in the 2023 report amounted to DKK -1,929,506.
- Revenue
- DKK 22,285
- Gross Profit
- DKK 12,472
- Profit/Loss
- DKK -30,932
- Equity
- DKK -1,929,506
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 22 t. | 12 t. | -31 t. | -1.9 mio. | - |
| 2022 | 43 t. | 33 t. | 65 t. | -1.9 mio. | - |
| 2021 | 0 | -10 t. | 3 t. | -2 mio. | - |
| 2020 | 0 | -13 t. | -46 t. | -2 mio. | 1 |
| 2019 | 47 t. | 19 t. | 25 t. | -1.9 mio. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
GB PHARMA ApS has published its annual report for 2022. Revenue came to DKK 42,725, and the net result was DKK 65,154.
About GB PHARMA ApS
GB PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2014. The company is registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The management consists of Gunnar Kjems. The board consists of Gunnar Kjems (chair). The company is owned by Gunnar Kjems. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -10,000 and a net result of DKK 31,613 compared with DKK -4,949 the year before. Equity in the 2025 report amounted to DKK -1,902,842.